“Which Factors Help to Determine the Long-Term Response to First-Line Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma: A Turkish Multi-Centre Study”. 2024. Biomolecules and Biomedicine 24 (6): 1776–1784. https://doi.org/10.17305/bb.2024.10512.